de Bollard Group Boston Scientific BSX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 786 M | Vender |
18,420,720
-111,453
| -0.6% | -USD 6.05 M | 23.93% | 1 |
|
|
2026
Q1 | USD 1163 M | Vender |
18,532,173
-468,296
| -2% | -USD 37.5 M | 34.26% | 1 |
|
|
2025
Q4 | USD 1812 M | Vender |
19,000,469
-733,104
| -4% | -USD 71.9 M | 45.28% | 1 |
|
|
2025
Q3 | USD 1927 M | Vender |
19,733,573
-345,870
| -2% | -USD 35.8 M | 45.28% | 1 |
|
|
2025
Q2 | USD 2157 M | Vender |
20,079,443
-411,383
| -2% | -USD 41.6 M | 49.31% | 1 |
|
|
2025
Q1 | USD 2067 M | Vender |
20,490,826
-242,400
| -1% | -USD 24.4 M | 54.28% | 1 |
|
|
2024
Q4 | USD 1852 M | Vender |
20,733,226
-510,325
| -2% | -USD 44.9 M | 51.33% | 1 |
|
|
2024
Q3 | USD 1780 M | Vender |
21,243,551
-419,750
| -2% | -USD 33.1 M | 47.36% | 1 |
|
|
2024
Q2 | USD 1668 M | Vender |
21,663,301
-335,320
| -2% | -USD 24.5 M | 47.07% | 1 |
|
|
2024
Q1 | USD 1507 M | Vender |
21,998,621
-392,890
| -2% | -USD 25.3 M | 45.57% | 1 |
|
|
2023
Q4 | USD 1294 M | Vender |
22,391,511
-953,215
| -4% | -USD 50.9 M | 45.01% | 1 |
|
|
2023
Q3 | USD 1233 M | Vender |
23,344,726
-330,355
| -1% | -USD 17.3 M | 45.36% | 1 |
|
|
2023
Q2 | USD 1281 M | Vender |
23,675,081
-432,545
| -2% | -USD 22.6 M | 43.56% | 1 |
|
|
2023
Q1 | USD 1206 M | Vender |
24,107,626
-353,200
| -1% | -USD 16.6 M | 43.57% | 1 |
|
|
2022
Q4 | USD 1132 M | Vender |
24,460,826
-1,278,765
| -5% | -USD 55.4 M | 43.24% | 1 |
|
|
2022
Q3 | USD 997 M | Vender |
25,739,591
-456,400
| -2% | -USD 18.3 M | 41.89% | 1 |
|
|
2022
Q2 | USD 976 M | Vender |
26,195,991
-437,881
| -2% | -USD 17.8 M | 39.56% | 1 |
|
|
2022
Q1 | USD 1180 M | Vender |
26,633,872
-329,826
| -1% | -USD 14.3 M | 37.74% | 1 |
|
|
2021
Q4 | USD 1145 M | Vender |
26,963,698
-193,215
| -0.7% | -USD 8.12 M | 36.67% | 1 |
|
|
2021
Q3 | USD 1178 M | Vender |
27,156,913
-2,628,079
| -9% | -USD 116 M | 38.6% | 1 |
|
|
2021
Q2 | USD 1274 M | Vender |
29,784,992
-1,590,099
| -5% | -USD 66.9 M | 40.38% | 1 |
|
|
2021
Q1 | USD 1213 M | Comprar |
31,375,091
+77,380
| +0.2% | +USD 2.93 M | 42.48% | 1 |
|
|
2020
Q4 | USD 1125 M | Vender |
31,297,711
-727,250
| -2% | -USD 26.2 M | 41.9% | 1 |
|
|
2020
Q3 | USD 1224 M | Vender |
32,024,961
-389,132
| -1% | -USD 15 M | 44.1% | 1 |
|
|
2020
Q2 | USD 1138 M | Vender |
32,414,093
-250,945
| -0.8% | -USD 9.04 M | 44.71% | 1 |
|
|
2020
Q1 | USD 1066 M | Vender |
32,665,038
-483,945
| -1% | -USD 18.9 M | 47.37% | 1 |
|
|
2019
Q4 | USD 1499 M | Vender |
33,148,983
-223,605
| -0.7% | -USD 9.36 M | 48.66% | 1 |
|
|
2019
Q3 | USD 1358 M | Vender |
33,372,588
-144,338
| -0.4% | -USD 6.12 M | 47.69% | 1 |
|
|
2019
Q2 | USD 1441 M | Vender |
33,516,926
-65,200
| -0.2% | -USD 2.51 M | 49.64% | 1 |
|
|
2019
Q1 | USD 1289 M | Mantener |
33,582,126
| – | – | 48.65% | 1 |
|
|
2018
Q4 | USD 1187 M | Comprar |
33,582,126
+14,000
| +0% | +USD 508 k | 52.34% | 1 |
|
|
2018
Q3 | USD 1292 M | Comprar |
33,568,126
+56,622
| +0.2% | +USD 1.98 M | 51.96% | 1 |
|
|
2018
Q2 | USD 1096 M | Vender |
33,511,504
-143,537
| -0.4% | -USD 4.33 M | 50.34% | 1 |
|
|
2018
Q1 | USD 919 M | Vender |
33,655,041
-199,076
| -0.6% | -USD 5.41 M | 45.71% | 1 |
|
|
2017
Q4 | USD 839 M | Comprar |
33,854,117
+118,050
| +0.3% | +USD 3.26 M | 40.34% | 1 |
|
|
2017
Q3 | USD 984 M | Mantener |
33,736,067
| – | – | 51.88% | 1 |
|
|
2017
Q2 | USD 935 M | Vender |
33,736,067
-1,422,495
| -4% | -USD 37.8 M | 50.51% | 1 |
|
|
2017
Q1 | USD 874 M | Comprar |
35,158,562
+26,300
| +0.1% | +USD 640 k | 50.14% | 1 |
|
|
2016
Q4 | USD 760 M | Comprar |
35,132,262
+481,488
| +1% | +USD 10.5 M | 49.57% | 1 |
|
|
2016
Q3 | USD 825 M | Comprar |
34,650,774
+853,713
| +3% | +USD 20.4 M | 52.75% | 1 |
|
|
2016
Q2 | USD 790 M | Comprar |
33,797,061
+7,727,095
| +30% | +USD 167 M | 53.96% | 1 |
|
|
2016
Q1 | USD 490 M | Vender |
26,069,966
-2,000
| -0% | -USD 35.1 k | 39.49% | 1 |
|
|
2015
Q4 | USD 481 M | Vender |
26,071,966
-300
| -0% | -USD 5.38 k | 39.58% | 1 |
|
|
2015
Q3 | USD 428 M | Vender |
26,072,266
-319,743
| -1% | -USD 5.47 M | 35.09% | 1 |
|
|
2015
Q2 | USD 467 M | Mantener |
26,392,009
| – | – | 35.28% | 1 |
|
|
2015
Q1 | USD 468 M | Mantener |
26,392,009
| – | – | 34.88% | 1 |
|
|
2014
Q4 | USD 350 M | Mantener |
26,392,009
| – | – | 30.86% | 1 |
|
|
2014
Q3 | USD 312 M | Comprar |
26,392,009
+11,525
| +0% | +USD 145 k | 29.43% | 1 |
|
|
2014
Q2 | USD 337 M | Vender |
26,380,484
-121,130
| -0.5% | -USD 1.58 M | 32.55% | 1 |
|
|
2014
Q1 | USD 358 M | Vender |
26,501,614
-351,500
| -1% | -USD 4.61 M | 36.24% | 1 |
|
|
2013
Q4 | USD 323 M | Comprar |
26,853,114
+746,130
| +3% | +USD 8.82 M | 35.59% | 1 |
|
|
2013
Q3 | USD 306 M | Comprar |
26,106,984
+14,273,365
| +121% | +USD 154 M | 36.05% | 1 |
|
|
2013
Q2 | USD 110 M | Comprar |
+11,833,619
| Nuevas | +USD 100 M | 21.1% | 1 |
|
Otros fondos que tienen BSX en su cartera
Posición de Bollard Group en BSX: resumen de T2 2026
Bollard Group redujo su participación en Boston Scientific (BSX) en 0.6% durante T2 2026, al vender acciones por un valor estimado de USD 6.05 M, y conservó 18,420,720 acciones valuadas en USD 786 M. La posición representa 23.93% de la cartera y ocupa el puesto #1.
Bollard Group reportó por primera vez una posición en BSX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 2157 M en T2 2025. Al cierre de T2 2026, 1,492 fondos que sigue Wall St. Rank mantienen una posición en BSX.
- Al cierre de T2 2026, Bollard Group tenía 18,420,720 acciones de Boston Scientific con un valor de USD 786 M.
- Bollard Group vendió 111,453 acciones de Boston Scientific en T2 2026, por un valor estimado de USD 6.05 M.
- Boston Scientific representó 23.93% de la cartera de Bollard Group en T2 2026 y fue su posición número 1.
- Bollard Group reportó por primera vez una posición en Boston Scientific en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Bollard Group en Boston Scientific alcanzó su máximo de USD 2157 M en T2 2025.
- Al cierre de T2 2026, 1,492 fondos que sigue Wall St. Rank tenían Boston Scientific en cartera.
Según el Informe 13F de Bollard Group correspondiente a T2 2026, presentado el 12 ago 2026.